Sanofi Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 90 Posts
1 2 3 ... 6
E Daily Stock Pick: Sanofi
Article By: Fredrik Arnold Wednesday, May 29, 2019 5:35 AM EDT
Sanofi's price per share closed at $41.33 yesterday. A year ago its price was $38.28.
In this article: SNY
Read
Week In Review: How Trump's Policies Moved Stocks - May 12, 2019
Article By: The Fly Sunday, May 12, 2019 6:43 AM EDT
Catch up on the top industries and stocks that were impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap.
In this article: AZN, BMY, GM, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, WKHS
Read
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Article By: Benzinga Saturday, April 27, 2019 6:05 PM EDT
Biotech stocks staged a recovery this week after being in the red in the previous two weeks.
In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV
Read
E Don't Cry For Me, Argentina
Article By: Vivian Lewis Sunday, September 9, 2018 10:28 AM EDT
Stronger currencies chopped the prices of most foreign stocks last week, a side effect of the move out of emerging markets currencies which is continuing, and out of the dollar, which is strengthening.
In this article: BUD, CZZ, GSK, LLY, NVS, SNY, TEI, VOD, CGRIF, OROCF, RHHBY, TEVA, GLD, ZYME
Read
Week In Review: Long Hill Capital Closes $265 Million Fund For China Healthcare
Article By: ChinaBio® Today Saturday, July 28, 2018 4:14 PM EDT
Long Hill Capital of Beijing and Shanghai, focused the healthcare and consumer sectors, closed its second fund at $265 million. Long Hill said it "significantly exceeded” its funding target, showing the success of its thesis-investing strategy.
In this article: BMY, MRK, SNY, CELG, BGNE
Read
Week In Review Ending July 22: How Trump's Policies Moved Stocks
Article By: The Fly Sunday, July 22, 2018 9:13 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: CAU, BA, F, GM, HMC, MRK, NVS, PFE, SNY, TM, DDAIF, NSANY, RHHBY, VLKAY, GOOG, GOOGL, FCAU
Read
The Top 11 Big Pharma Dividend Stocks Ranked By Total Return
Article By: SureDividend Monday, July 16, 2018 8:04 PM EDT
Drug companies are often considered defensive in nature due to their stable earnings, through good economies and bad.
In this article: LLY, MRK, AZN, BMY, AMGN, GILD, PFE, ABBV, GSK, NVS, SNY
Read
Week In Review: Suzhou Innovent Files For HK IPO - $500 Million Raise Rumored
Article By: ChinaBio® Today Saturday, July 7, 2018 4:06 PM EDT
Innovent Biologics of Suzhou has filed to IPO on the Hong Kong Exchange under its new rules for pre-revenue biopharmas. The company plans to raise as much as $500 million, according to media reports, at a valuation of over $1 billion.
In this article: LLY, SNY, SVA, BABA, ATNX
Read
Regeneron, Sanofi Say Odyssey Outcomes Trial Met Primary Endpoint
Article By: The Fly Saturday, March 10, 2018 5:27 PM EDT
Regeneron Pharmaceuticals and Sanofi announced that the Odyssey Outcomes trial met its primary endpoint. Praluent Injection "significantly reduced" risk of major adverse cardiovascular events in recent acute coronary syndrome patients.
In this article: SNY, REGN
Read
Warren Buffet Is Buying These 3 Stocks Right Now
Article By: TipRanks Sunday, February 18, 2018 8:45 AM EDT
Finding fresh investing inspiration can be a challenge, but if you examine billionaire Warren Buffett’s moves, you can find insights from one of the world’s most successful fund managers. Here are 3 stocks Buffett is buying and 3 he is selling...
In this article: BK, GM, IBM, SNY, AAPL, TEVA
Read
E Sh-Tdown To End
Article By: Vivian Lewis Monday, January 22, 2018 12:15 PM EDT
News today from Bermuda, Brazil, Britain, Canada, Chile, China, Colombia, Denmark, Dutch Antilles, France, Finland, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Panama, Sweden, Switzerland, and the USA where the sh-tdown is being ended.
In this article: AIG, CEA, SLFPY, NTR, BLX, BP, EONGY, SLB, EC, DGRLY, AGU, CB, CZZ, SQM, VR, XYL, PPEHF, SNY, TEVA, NVO, SHPG, MZOR, SANM, NOK, TCEHY, SAN, TCTZF, DCM, MXE, CTY Also: AMZN
Read
Sanofi Acquires Bioverativ For $105 Per Share In Cash, Or $11.6B
Article By: The Fly Monday, January 22, 2018 7:42 AM EDT
Sanofi and Bioverativ have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ for $105 per share in cash, representing an equity value of approximately $11.6B.
In this article: BIVV, SNY
Read
Sanofi (SNY) Q3 Earnings In Line, Sales Lag, Diabetes Weak
Article By: Zacks Investment Research Thursday, November 2, 2017 11:52 AM EDT
Sanofi reported third-quarter 2017 earnings of $1.00 per American depositary share, which were in line with the Zacks Consensus Estimate. Earnings declined 4.5% on a reported basis.
In this article: SNY Also: MRK, REGN, AMGN
Read
Week In Review: Another Billion Dollar Week For China Life Science Deals
Article By: ChinaBio® Today Saturday, September 30, 2017 5:55 PM EDT
Shanghai Pharma Holding (SHA: 601607) may acquire part of Alvogen -- possibly Alvogen's US operations -- according to Bloomberg. Alvogen is a US-based generic drug maker thought to be worth as much as $4 billion.
In this article: NVO, SNY, SVA, AMGN, GILD, ZLAB, TSRO
Read
Regeneron/Sanofi's Dupixent Asthma Study Meets Endpoints
Article By: Zacks Investment Research Monday, September 11, 2017 4:50 PM EDT
Regeneron Pharmaceuticals, Inc. and partner Sanofi announced that Dupixent (dupilumab) met its two primary endpoints in a phase III study conducted on patients with uncontrolled, persistent asthma.
In this article: SNY, REGN Also: ALXN, ADRO
Read
Forget Teva, Buy These 4 Drug Stocks Instead
Article By: Arpita Dutt Friday, August 11, 2017 1:17 PM EDT
It’s not been a good quarter for Israel-based generic drug maker, Teva Pharmaceutical Industries Limited. Teva missed on both second quarter earnings and revenues and lowered its outlook for 2017.
In this article: SNY, ALXN, REGN, GILD, TEVA
Read
1 to 16 of 90 Posts
1 2 3 ... 6